• E. L. Nasonov 
  • V. I. Mazurov
  • A. M. Lila
  • T. V. Dubinina
  • I. Z. Gaydukova
  • S. A. Lapshina
  • A. A. Klimenko
  • D. V. Somov
  • S. A. Lukianov
  • D. M. Chudakov
  • I. V. Zvyagin
  • O. V. Britanova
  • M. A. Korolev
  • D. I. Abdulganieva
  • D. G. Krechikova
  • A. A. Kastanayan
  • L. V. Eliseeva
  • R. R. Samigullina
  • T. V. Povarova
  • O. V. Antipova
  • S. A. Smakotina
  • V. N. Soboleva
  • O. B. Nesmeyanova
  • T. V. Plaksina
  • N. F. Soroka
  • I. B. Vinogradova
  • A. P. Rebrov
  • T. V. Kropotina
  • A. V. Zinkina-Orikhan
  • Yu. N. Lin’kova
  • P. S. Pukhtinskaia
  • M. A. Morozova
  • G. A. Vinderskaya
Translated title of the contributionEffectiveness and safety of BCD180, anti-TRBV9<sup>+</sup> T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA
Original languageRussian
Pages (from-to)65–80
Number of pages16
JournalНАУЧНО-ПРАКТИЧЕСКАЯ РЕВМАТОЛОГИЯ
Volume62
Issue number1
DOIs
StatePublished - 29 Feb 2024

ID: 117430095